Exhibit 25.1

FORM T-1

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF ELIGIBILITY
UNDER THE TRUST INDENTURE ACT OF 1939 OF A
CORPORATION DESIGNATED TO ACT AS TRUSTEE

CHECK IF AN APPLICATION TO DETERMINE ELIGIBILITY OF A TRUSTEE
PURSUANT TO SECTION 305(b)(2)     |     |

THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.
(Exact name of trustee as specified in its charter)

		95-3571558
(State of incorporation		(I.R.S. employer
if not a U.S. national bank)		identification no.)
700 S. Flower Street
2nd Floor
Los Angeles, California		90017-4104
(Address of principal executive offices)		(Zip code)

The Bank of New York Mellon Trust Company, N.A.
900 Ashwood Parkway — Suite 425
Atlanta, GA 30338
Attn: Lee Ann Willis
(770) 698-5131
(Name, address, and telephone number of agent for service)

(Exact name of obligor as specified in its charter)

Canada		98-0442987
(State or other jurisdiction of		(I.R.S. employer
incorporation or organization)		identification no.)
3399 Peachtree Road NE, Suite 1500		30326
Atlanta, Georgia		(Zip code)
(Address of principal executive offices)

(Title of the indenture securities)

TABLE 1

		State of		Primary Standard		IRS Employer
		Incorporation or		Industrial Classification		Identification
Guarantor*		Formation		Number		Number
Novelis Corporation		Texas		3350		41-2098321
Eurofoil Inc. (USA)		New York		3350		13-3783544
Novelis PAE Corporation		Delaware		3350		36-4266108
Aluminum Upstream Holdings LLC		Delaware		3350		20-5137700
Novelis Brand LLC		Delaware		3350		26-0442201
Novelis South America Holdings LLC		Delaware		3350		20-5137684
Novelis Cast House Technology Ltd.		Canada		3350		Not Applicable
Novelis No. 1 Limited Partnership		Canada		3350		Not Applicable
4260848 Canada Inc.		Canada		3350		Not Applicable
4260856 Canada Inc.		Canada		3350		Not Applicable
Novelis Europe Holdings Ltd.		United Kingdom		3350		Not Applicable
Novelis UK Ltd.		United Kingdom		3350		Not Applicable
Novelis Services Limited		United Kingdom		3350		Not Applicable
Novelis do Brasil Ltda.		Brazil		3350		Not Applicable
Novelis AG		Switzerland		3350		Not Applicable
Novelis Switzerland S.A.		Switzerland		3350		Not Applicable
Novelis Technology AG		Switzerland		3350		Not Applicable
Novelis Aluminium Holding Company		Ireland		3350		Not Applicable
Novelis Deutschland GmbH		Germany		3350		Not Applicable

		State of		Primary Standard		IRS Employer
		Incorporation or		Industrial Classification		Identification
Guarantor*		Formation		Number		Number
Novelis Luxembourg S.A.		Luxembourg		3350		Not Applicable
Novelis PAE S.A.S.		France		3350		Not Applicable

1. General information. Furnish the following information as to the trustee:

(a)

Name and address of each examining or supervising authority to which it is subject.

Name		Address
Comptroller of the Currency United States Department of the Treasury		Washington, D.C. 20219
Federal Reserve Bank		Atlanta, Georgia 30309
Federal Deposit Insurance Corporation		Washington, D.C. 20429

(b)

Whether it is authorized to exercise corporate trust powers.

     Yes.

2. Affiliations with Obligor.

     If the obligor is an affiliate of the trustee, describe each such affiliation.

     None.

16. List of Exhibits.

Exhibits identified in parentheses below, on file with the Commission, are incorporated herein by reference as an exhibit hereto, pursuant to Rule 7a-29 under the Trust Indenture Act of 1939 (the “Act”) and 17 C.F.R. 229.10(d).

	1.		A copy of the articles of association, as amended, of The Bank of New York Mellon Trust Company, N.A. formerly know as of The Bank of New York Trust Company, N.A. (Exhibit 1 to Form T-1 filed with Registration Statement No. 333-121948 and Exhibit 1 to Form T-1 filed with Registration Statement No. 333-152875).
	2.		A copy of certificate of authority of the trustee to commence business. (Exhibit 2 to Form T-1 filed with Registration Statement No. 333-121948).
	3.		A copy of the authorization of the trustee to exercise corporate trust powers. (Exhibit 3 to Form T-1 filed with Registration Statement No. 333-152875).
	4.		A copy of the existing by-laws of the trustee. (Exhibit 4 to Form T-1 filed with Registration Statement No. 333-152875).
	6.		The consent of the trustee required by Section 321(b) of the Act. (Exhibit 6 to Form T-1 filed with Registration Statement No. 333-152875).
	7.		A copy of the latest report of condition of the Trustee published pursuant to law or to the requirements of its supervising or examining authority.

SIGNATURE

     Pursuant to the requirements of the Act, the trustee, The Bank of New York Mellon Trust Company, N.A., a corporation organized and existing under the laws of the United States of America, has duly caused this statement of eligibility to be signed on its behalf by the undersigned, thereunto duly authorized, all in The City of Atlanta, and State of Georgia, on the 11^th day of September, 2009.

		THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.
		By:		/s/ Lee Ann Willis
		Name: Lee Ann Willis
		Title: Senior Associate

EXHIBIT 7

Consolidated Report of Condition of
THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.
of 700 South Flower Street, Suite 200, Los Angeles, CA 90017

     At the close of business June 30, 2009, published in accordance with Federal regulatory authority instructions.

				Dollar Amounts
				in Thousands
ASSETS
Cash and balances due from depository institutions:
Noninterest-bearing balances and currency and coin					4,627
Interest-bearing balances					111,263
Securities:
Held-to-maturity securities					22
Available-for-sale securities					492,259
Federal funds sold and securities purchased under agreements to resell:
Federal funds sold					0
Securities purchased under agreements to resell					0
Loans and lease financing receivables:
Loans and leases held for sale					0
Loans and leases, net of unearned income			0
LESS: Allowance for loan and lease losses			0
Loans and leases, net of unearned income and allowance					0
Trading assets					0
Premises and fixed assets (including capitalized leases)					11,783
Other real estate owned					0
Investments in unconsolidated subsidiaries and associated companies					1
Direct and indirect investments in real estate ventures					0
Intangible assets:
Goodwill					876,153
Other intangible assets					258,262
Other assets					157,588
Total assets				$	1,911,958

				Dollar Amounts
				in Thousands
LIABILITIES
Deposits:
In domestic offices					599
Noninterest-bearing		599
Interest-bearing		0
Not applicable
Federal funds purchased and securities sold under agreements to repurchase:
Federal funds purchased					0
Securities sold under agreements to repurchase					0
Trading liabilities					0
Other borrowed money:
(includes mortgage indebtedness and obligations under capitalized leases)					268,691
Not applicable
Not applicable
Subordinated notes and debentures					0
Other liabilities					195,831
Total liabilities					465,121
Not Applicable
EQUITY CAPITAL
Perpetual preferred stock and related surplus					0
Common stock					1,000
Surplus (exclude all surplus related to preferred stock)					1,121,520
Not Applicable
Retained earnings					321,726
Accumulated other comprehensive income					2,591
Other equity capital components					0
Not Available
Total bank equity capital					1,446,837
Noncontrolling (minority) interests in consolidated subsidiaries					0
Total equity capital					1,446,837
Total liabilities and equity capital					1,911,958

     I, Karen Bayz, Vice President of the above-named bank do hereby declare that the Reports of Condition and Income (including the supporting schedules) for this report date have been prepared in conformance with the instructions issued by the appropriate Federal regulatory authority and are true to the best of my knowledge and belief.

     Karen Bayz      )      Managing Director

     We, the undersigned directors (trustees), attest to the correctness of the Report of Condition (including the supporting schedules) for this report date and declare that it has been examined by us and to the best of our knowledge and belief has been prepared in conformance with the instructions issued by the appropriate Federal regulatory authority and is true and correct.

Troy Kilpatrick, MD

)

Frank P. Sulzberger, MD

)

Directors (Trustees)

William D. Lindelof, VP

)